Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.0004 USD
Change Today 0.00 / 0.00%
Volume 36.3M
As of 12:22 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

multicell technologies inc (MCET) Snapshot

Open
$0.0003
Previous Close
$0.0004
Day High
$0.0004
Day Low
$0.0003
52 Week High
08/25/14 - $0.0015
52 Week Low
12/29/14 - $0.0002
Market Cap
1.9M
Average Volume 10 Days
12.9M
EPS TTM
$-0.0001
Shares Outstanding
4.9B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MULTICELL TECHNOLOGIES INC (MCET)

Related News

No related news articles were found.

multicell technologies inc (MCET) Related Businessweek News

No Related Businessweek News Found

multicell technologies inc (MCET) Details

MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprise MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; MCT-475, a discovery stage antibody therapeutic candidate used in combination with dsRNA for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.

2 Employees
Last Reported Date: 03/2/15
Founded in 1962

multicell technologies inc (MCET) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $177.5K
Compensation as of Fiscal Year 2014.

multicell technologies inc (MCET) Key Developments

MultiCell Technologies, Inc. Annual Meeting of Stockholders Approves an Amendment to its Amended and Restated Certificate of Incorporation

MultiCell Technologies, Inc. announced that at its Annual Meeting of Stockholders held on March 11, 2015, the shareholders approved the proposal was to approve an amendment to the company's Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of the company's common stock to a total of 10.0 billion shares.

MultiCell Technologies, Inc. Auditor Raises 'Going Concern' Doubt

MultiCell Technologies, Inc. filed its 10-K on Mar 02, 2015 for the period ending Nov 30, 2014. In this report its auditor, Eide Bailly, LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Multicell Technologies, Inc. to Approve Amendment to Amended and Restated Certificate of Incorporation

MultiCell Technologies, Inc. announced that the annual general meeting to be held on January 22, 2015, to approve an amendment to the Amended and Restated Certificate of Incorporation, as amended, to effect an increase in the number of authorized shares of the company's common stock to a total of 10 billion shares.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MCET:US $0.00 USD 0.00

MCET Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MCET.
View Industry Companies
 

Industry Analysis

MCET

Industry Average

Valuation MCET Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 38.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 52.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MULTICELL TECHNOLOGIES INC, please visit www.multicelltech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.